Widely used GLP-1 receptor agonists, commonly prescribed for type 2 diabetes and obesity, may be associated with a small increase…
Browsing: Clinical Updates
The FDA has cleared the Xpert GI Panel from Cepheid, a multiplex PCR test that detects 11 gastrointestinal pathogens from…
February 2026 was defined by durability data and real-world insight across inflammatory bowel disease (IBD), with multiple long-term analyses presented…
Despite being largely preventable, colorectal cancer (CRC) remains the second leading cause of cancer death in the United States, highlighting…
A new evaluation from the Peterson Health Technology Institute finds that virtual gastrointestinal care programs can improve patient outcomes while…
Targeted therapy has officially entered the first-line standard of care for a high-risk molecular subset of metastatic colorectal cancer (mCRC).…
Virtual multidisciplinary GI care is moving from pilot data to scaled performance metrics. Oshi Health released its 2025 Impact Report,…
A large Swedish randomized trial (SCREESCO), published in Nature Medicine, evaluated over 278,000 60-year-olds assigned to: Unlike most prior trials,…
The third week of February brings a wide-ranging set of updates across GI oncology, reflecting continued progress in both biological…
The FORTE trial is a large randomized clinical study evaluating whether patients with 1–2 non-advanced adenomatous polyps benefit from earlier…